The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Omnipaque 350 mg I/ml Solution for Injection (Polypropylene)



GE Healthcare ASPA0735/006/020

Main Information

Trade NameOmnipaque 350 mg I/ml Solution for Injection (Polypropylene)
Active SubstancesIohexol
Dosage FormSolution for injection
Licence HolderGE Healthcare AS
Licence NumberPA0735/006/020

Group Information

ATC CodeV08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
V08AB02 iohexol

Status

License statusAuthorised
Licence Issued11/11/1993
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceRestricted to hospital dispensing
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back